• LAST PRICE
    69.7200
  • TODAY'S CHANGE (%)
    Trending Down-7.1600 (-9.3132%)
  • Bid / Lots
    69.5300/ 7
  • Ask / Lots
    69.9100/ 4
  • Open / Previous Close
    76.5700 / 76.8800
  • Day Range
    Low 69.5400
    High 77.0000
  • 52 Week Range
    Low 13.5000
    High 86.9300
  • Volume
    240,744
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 76.88
TimeVolumePRAX
09:32 ET611775
09:33 ET10076.25
09:35 ET65075.75
09:37 ET55774.67
09:39 ET10075.05
09:42 ET596073.1841
09:44 ET43174
09:46 ET30073.85
09:50 ET95073.06
09:51 ET10073.26
09:55 ET20073.565
09:57 ET427673.465
10:00 ET30074.06
10:02 ET15074.175
10:04 ET22874.175
10:06 ET52673.555
10:08 ET10073.87
10:11 ET40074.135
10:13 ET70073.2
10:18 ET1547171.8182
10:20 ET20072.17
10:22 ET50071.27
10:24 ET50070.79
10:26 ET10070.78
10:27 ET110070.74
10:29 ET40071.01
10:33 ET32271.4
10:36 ET10071
10:38 ET40071.475
10:42 ET110171.252
10:45 ET50071.15
10:47 ET160071.07
10:49 ET10071.1
10:54 ET62170.5
10:56 ET20070.5
10:58 ET80070.22
11:00 ET10070.01
11:02 ET10070.01
11:03 ET82470.16
11:05 ET254270.48
11:07 ET260071.135
11:09 ET251771.105
11:12 ET141870.73
11:14 ET60070.73
11:16 ET233271.15
11:18 ET27971.15
11:20 ET91571.15
11:21 ET30071.15
11:23 ET87470.84
11:25 ET30070.905
11:27 ET100570.67
11:30 ET30071.015
11:32 ET10070.66
11:34 ET20070.45
11:36 ET30070.44
11:39 ET80070.285
11:41 ET90069.84
11:43 ET20069.84
11:45 ET117969.84
11:48 ET200470.79
11:52 ET10070.905
11:54 ET20070.91
11:56 ET120070.53
11:59 ET138070.615
12:01 ET30070.62
12:08 ET80070.4
12:10 ET10070.4
12:12 ET30070.33
12:14 ET10070.34
12:15 ET200169.72
12:17 ET215870.27
12:21 ET100270.78
12:26 ET10071.02
12:28 ET150070.6
12:30 ET10070.63
12:32 ET324271.25
12:33 ET437671.58
12:35 ET47071.1561
12:37 ET129370.93
12:39 ET150071.33
12:42 ET30071.33
12:44 ET30071.08
12:46 ET52271.295
12:50 ET10071.01
12:51 ET173371.01
12:53 ET10070.69
12:55 ET318970.36
12:57 ET20070.42
01:00 ET20070.5
01:02 ET20070.635
01:04 ET40070.5
01:06 ET80070.495
01:08 ET50070.47
01:09 ET300070.36
01:11 ET100070.71
01:13 ET60070.535
01:15 ET20070.535
01:18 ET278070.405
01:20 ET222570.32
01:22 ET147770.52
01:24 ET20070.55
01:29 ET10070.42
01:31 ET317970.845
01:33 ET10071.08
01:38 ET50070.845
01:40 ET448070.725
01:44 ET156370.71
01:45 ET20070.42
01:47 ET117570.42
01:49 ET20070.09
01:51 ET199169.915
01:54 ET30069.915
01:56 ET20069.59
01:58 ET129469.77
02:00 ET10069.77
02:02 ET321969.77
02:03 ET518170.19
02:05 ET20070.5
02:07 ET80070.3
02:09 ET10070.64
02:12 ET110070.365
02:14 ET20070.28
02:16 ET30070.27
02:18 ET168770.315
02:20 ET10070.52
02:21 ET246369.79
02:23 ET480070.09
02:25 ET60069.74
02:27 ET110069.92
02:30 ET20069.68
02:32 ET40069.92
02:34 ET395069.84
02:36 ET30069.81
02:38 ET559669.59
02:39 ET20069.72
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRAX
Praxis Precision Medicines Inc
1.4B
-6.8x
---
United StatesSNDX
Syndax Pharmaceuticals Inc
1.4B
-4.4x
---
United StatesDAWN
Day One Biopharmaceuticals Inc
1.4B
-13.1x
---
United StatesUPB
Upstream Bio Inc
1.4B
0.0x
---
United StatesSPRY
ARS Pharmaceuticals Inc
1.4B
-27.1x
---
United StatesRCKT
Rocket Pharmaceuticals Inc
1.3B
-5.1x
---
As of 2024-11-15

Company Information

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.

Contact Information

Headquarters
99 High Street, 30th FloorBOSTON, MA, United States 02110
Phone
617-300-8460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dean Mitchell
President, Chief Executive Officer, Director
Marcio Souza
Chief Financial Officer
Timothy Kelly
Vice President - Legal
Alex Nemiroff
Independent Director
Jeffrey Chodakewitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4B
Revenue (TTM)
$1.6M
Shares Outstanding
18.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.69
EPS
$-10.29
Book Value
$7.92
P/E Ratio
-6.8x
Price/Sales (TTM)
892.8
Price/Cash Flow (TTM)
---
Operating Margin
-10,219.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.